News & Articles

AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro

Anaerobic workstations from Don Whitley Scientific are being used to develop novel microbial technology for biotherapeutics

Discover the latest technology for the identification of structural variants (SVs) within the human genome

Pioneering microbiome scientist Prof. Patrice Cani reveals how his work has unearthed some of the most groundbreaking discoveries in the world of gut microbes, and how they influence human physiology

Find out how two distinct single-cell RNA-seq approaches were used to create a large-scale Cell Atlas, with this on-demand expert webinar

Reagent-free system identifies microorganisms from isolated colonies with minimal manual work and no sample prep

Next-generation sequencing oligo products to be used in groundbreaking food safety platform

Visitors to earn continuing professional development (CPD) points in the free-to-attend conference programme

Combination of Tecentriq and chemotherapy has demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit

Akoya Biosciences determines that multiplex immunofluorescence technology preserves critical data missed by other biomarker strategies

New polymers can reduce the amount of organic solvent required in cryopreservation, as well as giving more and healthier cells after thawing

Landmark 15-year study funded by the MS Society has potential to predict the progression of the condition

Rigaku Oxford Diffraction will show latest technology at the 32nd European Crystallographic Meeting

Learn more about this FDA-cleared, intermediate glycemic control marker for diabetes at AACC Clinical Lab Expo 2019

Designed for quantitative analysis, Waters' full portfolio of TQ MS systems makes high performance and routine analysis accessible, robust, reliable

Calendar-based plug-in for Biosero's Green Button Go Software eliminates bottlenecks on high-value lab equipment

RSV test represents expansion of FDA-cleared, CLIA-waived and CE-marked PCR point-of-care testing portfolio

Neuroimmunologist Dr. Timothy Hammond, from Boston Children’s Hospital, reveals how his research into microglial activation is opening up new avenues for therapeutic intervention in devastating neurological diseases